ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pharmacological mechanisms of sinomenine in anti-inflammatory immunity and osteoprotection in rheumatoid arthritis: A systematic review

Li, Juan -Min; Yao, Yun-Da; Luo, Jin-Fang; Liu, Jian-Xin; Liu, Zhong-Qiu; Dong, Yan*; Xie, Ying*; Zhou, Hua*广东省人民医院; 广州中医药大学; 贵州大学; y
PHYTOMEDICINE2023-12DOI: 10.1016/j.phymed.2023.155114
7阅读
引用收藏
分享

摘要

Background: Sinomenine (SIN) is the main pharmacologically active component of Sinomenii Caulis and protects against rheumatoid arthritis (RA). In recent years, many studies have been conducted to elucidate the pharmacological mechanisms of SIN in the treatment of RA. However, the molecular mechanism of SIN in RA has not been fully elucidated. @@@ Purpose: To summarize the pharmacological effects and molecular mechanisms of SIN in RA and clarify the most valuable regulatory mechanisms of SIN to provide clues and a basis for basic research and clinical applications. @@@ Methods: We systematically searched SciFinder, Web of Science, PubMed, China National Knowledge Internet (CNKI), the Wanfang Databases, and the Chinese Scientific Journal Database (VIP). We organized our work based on the PRISMA statement and selected studies for review based on predefined selection criteria. @@@ Outcome: After screening, we identified 201 relevant studies, including 88 clinical trials and 113 in vivo and in vitro studies on molecular mechanisms. Among these studies, we selected key results for reporting and analysis. @@@ Conclusions: We found that most of the known pharmacological mechanisms of SIN are indirect effects on certain signaling pathways or proteins. SIN was manifested to reduce the release of inflammatory cytokines such as Tumor necrosis factor-alpha (TNF-alpha), Interleukin-6 (IL-6), and IL-1 beta, thereby reducing the inflammatory response, and apparently blocking the destruction of bone and cartilage. The regulatory effects on inflammation and bone destruction make SIN a promising drug to treat RA. More notably, we believe that the modulation of alpha 7nAChR and the regulation of methylation levels at specific GCG sites in the mPGES-1 promoter by SIN, and its mechanism of directly targeting GBP5, certainly enriches the possibilities and the underlying rationale for SIN in the treatment of inflammatory immune-related diseases.

学科与关键词

关键词
SinomenineRheumatoid arthritisInflammationBone destructionalpha 7nAChRmPGES-1GBP5
相关
加载中…
  • Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways
    Li, Juan-min; Deng, Hai-shan; Yao, Yun-da; Wang, Wei-ting; Hu, Jia-qin; Dong, Yan; Wang, Pei-xun; Liu, Liang; Liu, Zhong-qiu*; Xie, Ying*; Lu, Lin-lin*; Zhou, Hua*Acta Pharmacologica Sinica, 2023, 44(12): 2504-2524.被引 2
  • The Correlation Between Decreased Ornithine Level and Alleviation of Rheumatoid Arthritis Patients Assessed by a Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Sinomenine
    Shi, Ying; Pan, Hu-Dan; Wu, Jian-Lin; Zou, Qing-Hua; Xie, Xin-Yi; Li, Hong-Gang; Zhou, Hua; Bian, Xi-Qing; Leng, Wen-Fei; Wang, Can-Jian; Wang, Ya-Feng; Fang, Yong-Fei*; Liu, Liang*Engineering, 2022, 16: 93-99.被引 4
  • IDENTIFICATION OF NEW BIOMARKERS FOR SINOMENINE TREATMENT IN RHEUMATOID ARTHRITIS BASED ON BIOINFORMATICS ANALYSIS
    Shen, X.; Yanqun, L.; Guo, X.; Linfeng, W.; Zhang, J.; Feng, Z.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2023-12
卷期
第 121 卷
页码
155114
DOI
10.1016/j.phymed.2023.155114
语言
GERMAN
成果收录
SCIE
资助标注
Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao of National Natural Science Fund of China [81929003, 81628016]; National Natural Science Fund of China [8216140904]; 2020 Hunan Province Science and Technology Innovation Key Projects [2020SK1020]; Shenzhen Science and Technology Innovation Commission Shenzhen Basic Research Special Project (Natural Science Foundation) Basic Research Key Project [JCYJ20220818103402006]; Open Research Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2022KF09]; Sanming Project of Medicine in Shenzhen, Guangdong Province, China [SZZYSM202111002]; Research and Development Plan in Key Areas of Guangdong Province [2022B1111020005]

作者

  • L

    Li, Juan -Min (第一作者)

    guangzhou univ chinese med · 2 · guangdong prov acad chinese med sci · guangdong prov hosp

  • Y

    Yao, Yun-Da

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

查看全部 8 位作者收起作者
  • L

    Luo, Jin-Fang

    guizhou univ

  • L

    Liu, Jian-Xin

    hunan univ

  • L

    Liu, Zhong-Qiu

    guangzhou univ chinese med

  • D

    Dong, Yan (通讯)

    guangzhou univ chinese med

  • X

    Xie, Ying (通讯)

    2 · guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhou, Hua (通讯)

    guangzhou univ chinese med · 2 · guangdong prov acad chinese med sci · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417